US8399446 — Methods of treating hypertriglyceridemia
Method of Use · Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2030-02-09 · 4y remaining
What this patent protects
This patent protects methods of treating and/or preventing cardiovascular-related disease by administering a pharmaceutical composition containing eicosapentaenoic acid or a derivative thereof.
USPTO Abstract
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1287 |
— | Vascepa |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.